Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Genomics & Proteomics

• Publication date

  2014-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 25422359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.

  2012cited by this paper
• Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling.

  2012cited by this paper
• [Analysis of indoleamine 2, 3-dioxygenase expression in breast cancer patients with bone metastasis].

  2012cited by this paper
• Lactate and glycine—potential MR biomarkers of prognosis in estrogen receptor‐positive breast cancers

  2012cited by this paper
• Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies.

  2012cited by this paper
• Polyamines in aging and disease

  2011cited by this paper
• Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression.

  2011cited by this paper
• Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

  2011cited by this paper
• Higher population‐based incidence rates of triple‐negative breast cancer among young African‐American women

  2011cited by this paper
• Early detection of recurrent breast cancer using metabolite profiling.

  2010cited by this paper
• Organization of GC/MS and LC/MS metabolomics data into chemical libraries

  2010cited by this paper
• Triple-Negative Breast Cancer: A Short Review

  2010cited by this paper
• Early Detection of Recurrent Breast Cancer Using Metabolite Profiling

  2010cited by this paper
• Merging transcriptomics and metabolomics - advances in breast cancer profiling

  2010cited by this paper
• Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development.

  2010cited by this paper
• Rosen's Breast Pathology

  2009cited by this paper
• Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

  2009cited by this paper
• Clinical Applications of Metabolomics in Oncology: A Review

  2009cited by this paper
• Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems.

  2009cited by this paper
• Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes.

  2008cited by this paper
• Analysis of the adult human plasma metabolome.

  2008cited by this paper
• Role of ornithine decarboxylase in breast cancer.

  2008cited by this paper
• MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status

  2007cited by this paper
• Molecular Breast Cancer Subtypes in Premenopausal African-American Women, Tumor Biologic Factors and Clinical Outcome

  2007cited by this paper
• Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype

  2007cited by this paper
• Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer

  2006cited by this paper
• Comparative Metabolomics of Breast Cancer

  2006cited by this paper
• Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

  2006cited by this paper
• Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation

  2006cited by this paper
• Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters

  2006cited by this paper
• Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

  2005cited by this paper
• Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

  2005cited by this paper
• Metabolomics in practice: emerging knowledge to guide future dietetic advice toward individualized health.

  2005cited by this paper
• Metabolomics: building on a century of biochemistry to guide human health

  2005cited by this paper
• Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics.

  2005cited by this paper
• Ethnicity and breast cancer: factors influencing differences in incidence and outcome.

  2005cited by this paper
• Fatty acid synthase: A metabolic oncogene in prostate cancer?

  2004cited by this paper
• Metabolomics in the opening decade of the 21st century: building the roads to individualized health.

  2004cited by this paper
• Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis

  2004cited by this paper
• Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Estrogen Receptor/Progesterone Receptor-Negative Breast Cancers of Young African-American Women Have a Higher Frequency of Methylation of Multiple Genes than Those of Caucasian Women1

  2004cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Differences in breast cancer stage, treatment, and survival by race and ethnicity.

  2003cited by this paper
• Socioeconomic status and breast carcinoma survival in four racial/ethnic groups

  2003cited by this paper
• Statistical significance for genomewide studies

  2003cited by this paper
• Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women.

  2002cited by this paper
• Hormone Receptors in Breast Cancer: Racial Differences in Distribution and Survival

  2002cited by this paper
• Metabolic profiling of cell growth and death in cancer: applications in drug discovery.

  2002cited by this paper
• High‐resolution magic angle spinning MRS of breast cancer tissue

  2002cited by this paper
• Racial disparities in the quality of care for enrollees in medicare managed care.

  2002cited by this paper
• Rosen's Breast Pathology: Second Edition

  2002cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Tumor characteristics in African American and white women

  2001cited by this paper
• Gamma Glutamyl Transferase

  2001cited by this paper
• Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy.

  1999cited by this paper
• Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.

  1999cited by this paper
• Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy.

  1998cited by this paper
• Mammography Use Helps To Explain Differences in Breast Cancer Stage at Diagnosis between Older Black and White Women

  1998cited by this paper
• Oncogenes in Tumor Metabolism, Tumorigenesis, and Apoptosis

  1997cited by this paper
• Hormone receptor status of breast tumors in black, Hispanic, and non‐Hispanic white women: An analysis of 13,239 cases

  1996cited by this paper
• Histological characteristics of breast carcinoma in blacks and whites.

  1994cited by this paper
• Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression.

  1993cited by this paper
• Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide.

  1989cited by this paper
• A comparison of estrogen and progesterone receptors in black and white breast cancer patients.

  1987cited by this paper
• Copyright © American Society for Investigative Pathology Short Communication Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome

  year unknowncited by this paper

• The Role of Multi-Omics in Breast Cancer Diagnosis and Research

  2025cites this paper
• Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO/m6A/ANGPTL4/integrin axis in triple-negative breast cancer

  2025cites this paper
• Lipid dysregulation in triple negative breast cancer: Insights from mass spectrometry-based approaches.

  2025cites this paper
• Landscape of metabolic alterations and treatment strategies in breast cancer

  2025cites this paper
• Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBC

  2025cites this paper
• Detecting Glutathione and Related Antioxidants as Biomarkers in Patient Breast Tumor Tissues: An Update in the Age of Metabolomics

  2025influential citation
• Breast Cancer Progression by the FGF/FGFR Axis: A Metabolic Perspective

  2025cites this paper
• Metabolomics Biomarkers for Breast Cancer: An updated perspective.

  2025cites this paper
• Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3β/β-catenin/EMT pathway.

  2024cites this paper
• 1H-NMR metabolomics analysis identifies hypoxanthine as a novel metastasis-associated metabolite in breast cancer

  2024cites this paper
• Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis

  2024cites this paper
• Comparative Analysis of Breast Cancer Metabolomes Highlights Fascin’s Central Role in Regulating Key Pathways Related to Disease Progression

  2024cites this paper
• A critical appraisal of the role of metabolomics in breast cancer research and diagnostics.

  2024cites this paper
• Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer.

  2024cites this paper
• Free Salivary Amino Acid Profile in Breast Cancer: Clinicopathological and Molecular Biological Features

  2024cites this paper
• A lactate‐responsive gene signature predicts the prognosis and immunotherapeutic response of patients with triple‐negative breast cancer

  2024cites this paper
• Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBC

  2024cites this paper
• Metabolomic Signatures of Scarff–Bloom–Richardson (SBR) Grade in Non-Metastatic Breast Cancer

  2023cites this paper
• Metabolomics and triple-negative breast cancer: A systematic review

  2023influential citation
• Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma

  2023cites this paper
• Advances in Research on the Relationship between Glutamine Metabolism and Breast Cancer

  2023cites this paper
• GLUL gene knockdown and restricted glucose level show synergistic inhibitory effect on the luminal subtype breast cancer MCF7 cells’ proliferation and metastasis

  2023cites this paper
• Identification of metabolic pathways contributing to ER+ breast cancer disparities using a machine-learning pipeline

  2023cites this paper
• Updated Biomarkers for TNBC in African vs. Caucasian American Women

  2023cites this paper
• Lipidomic Profiling Reveals Biological Differences between Tumors of Self-Identified African Americans and Non-Hispanic Whites with Cancer

  2023cites this paper
• Metabolomics and the Multi-Omics View of Cancer

  2022cites this paper
• Inverse Correlation of KISS1 and KISS1R Expression in Triple-negative Breast Carcinomas from African American Women

  2022cites this paper
• Characterization of the Metabolome of Breast Tissues from Non-Hispanic Black and Non-Hispanic White Women Reveals Correlations between Microbial Dysbiosis and Enhanced Lipid Metabolism Pathways in Triple-Negative Breast Tumors

  2022cites this paper
• Metabolomics of Breast Cancer: A Review

  2022cites this paper
• The crosstalk of the human microbiome in breast and colon cancer: A metabolomics analysis.

  2022cites this paper
• Optimization and normalization strategies for long term untargeted HILIC-LC-qTOF-MS based metabolomics analysis: Early diagnosis of breast cancer

  2022cites this paper
• How previous treatment changes the metabolomic profile in patients with metastatic breast cancer

  2022cites this paper
• Impact of the Pd2Spm (Spermine) Complex on the Metabolism of Triple-Negative Breast Cancer Tumors of a Xenograft Mouse Model

  2021cites this paper
• Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis

  2021cites this paper
• Quantitative analysis of γ-glutamylisoleucine, γ-glutamylthreonine, and γ-glutamylvaline in HeLa cells using UHPLC-MS/MS.

  2021cites this paper
• Quantitative stain-free imaging and digital profiling of collagen structure reveal diverse survival of triple negative breast cancer patients

  2020cites this paper
• Effective electrochemotherapy with curcumin in MDA-MB-231-human, triple negative breast cancer cells: A global proteomics study.

  2020cites this paper
• Metabolomics-Based Discovery of Molecular Signatures for Triple Negative Breast Cancer in Asian Female Population

  2020cites this paper
• G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer

  2020cites this paper
• Elucidating the molecular signaling pathways of WAVE3.

  2020cites this paper
• The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer

  2020cites this paper
• Distinguishing metastatic triple‐negative breast cancer from nonmetastatic breast cancer using second harmonic generation imaging and resonance Raman spectroscopy

  2020cites this paper
• Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression

  2020cites this paper
• Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer

  2020influential citation
• Clinicopathological, Treatment and Event-Free Survival Characteristics in a Moroccan Population of Triple-Negative Breast Cancer

  2020cites this paper
• Metabolism and immunity in breast cancer

  2020cites this paper
• Optimization and validation of a HILIC-LC-ESI-MS/MS method for the simultaneous analysis of targeted metabolites: Cross validation of untargeted metabolomic studies for early diagnosis of breast cancer

  2020cites this paper
• Targeted metabolomics reveals dynamic portrayal of amino acids and derivatives in triple-negative breast cancer cells and culture media.

  2020cites this paper
• Cancer Omics in Africa: Present and Prospects

  2020cites this paper
• Metabolomic characterization of colorectal cancer cell lines highlighting stage-specific alterations during cancer progression

  2020cites this paper
• Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications

  2019cites this paper
• Oncogenic LncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression

  2019cites this paper
• Breast Cancer Metabolomics: From Analytical Platforms to Multivariate Data Analysis. A Review

  2019influential citation
• Prognostic Insight to Breast Cancer Markers in Nigeria

  2019cites this paper
• Evolution of Breast Cancer Classification Towards Personalized Medicine

  2019cites this paper
• Current Status and Future Prospects of Clinically Exploiting Cancer-specific Metabolism—Why Is Tumor Metabolism Not More Extensively Translated into Clinical Targets and Biomarkers?

  2019cites this paper
• ANXA2 expression in African American triple-negative breast cancer patients

  2018cites this paper
• Glutamate dehydrogenase (GLUD1) expression in breast cancer

  2018cites this paper
• Racial disparity in breast cancer: can it be mattered for prognosis and therapy

  2018cites this paper
• Amino Acid Transporters and Glutamine Metabolism in Breast Cancer

  2018cites this paper
• Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences

  2018cites this paper
• Metabolomics in breast cancer: A decade in review.

  2018cites this paper
• Untargeted and stable isotope-assisted metabolomic analysis of MDA-MB-231 cells under hypoxia

  2018cites this paper
• Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations

  2018cites this paper
• Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry

  2018cites this paper
• Computational metabolomics hints at the relevance of glutamine metabolism in breast cancer

  2018cites this paper
• Metabolic Footprints and Molecular Subtypes in Breast Cancer

  2017cites this paper
• Triple Negative Breast Cancer: Incidence Rates; Phenotype, Demographic, and Treatment Characteristics; Model for Risk Prediction Among Women of Color

  2017cites this paper
• Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer

  2017cites this paper
• Endocrinology meets metabolomics : 1 achievements , pitfalls , and challenges 2 3 4

  2017cites this paper
• Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers

  2017cites this paper
• A plasma metabolomic signature discloses human breast cancer

  2017cites this paper
• Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

  2017cites this paper
• In vivo Reprogramming of Cancer Metabolism by MYC

  2017cites this paper
• Endocrinology Meets Metabolomics: Achievements, Pitfalls, and Challenges.

  2017cites this paper
• Racial disparity in metabolic regulation of cancer.

  2017cites this paper
• PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis

  2017cites this paper
• Metabolomics in Cancer Biomarker Research

  2016cites this paper
• Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.

  2016cites this paper
• Alterations of the exo- and endometabolite profiles in breast cancer cell lines: A mass spectrometry-based metabolomics approach.

  2016cites this paper
• Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer

  2016cites this paper
• Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer

  2016cites this paper
• Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis

  2016cites this paper
• Hormonal and HER 2 Receptor Immunohistochemistry of Breast Cancer in North-Eastern Nigeria : a preliminary report

  2016cites this paper
• Efficacy and prognosis of neoadjuvant chemotherapy is correlated with breast cancer molecular classification.

  2015cites this paper